1. Home
  2. PCRX vs MUJ Comparison

PCRX vs MUJ Comparison

Compare PCRX & MUJ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PCRX
  • MUJ
  • Stock Information
  • Founded
  • PCRX 2006
  • MUJ 1998
  • Country
  • PCRX United States
  • MUJ United States
  • Employees
  • PCRX N/A
  • MUJ N/A
  • Industry
  • PCRX Biotechnology: Pharmaceutical Preparations
  • MUJ Investment Bankers/Brokers/Service
  • Sector
  • PCRX Health Care
  • MUJ Finance
  • Exchange
  • PCRX Nasdaq
  • MUJ Nasdaq
  • Market Cap
  • PCRX 1.2B
  • MUJ 602.6M
  • IPO Year
  • PCRX 2011
  • MUJ N/A
  • Fundamental
  • Price
  • PCRX $26.59
  • MUJ $11.51
  • Analyst Decision
  • PCRX Buy
  • MUJ
  • Analyst Count
  • PCRX 10
  • MUJ 0
  • Target Price
  • PCRX $29.30
  • MUJ N/A
  • AVG Volume (30 Days)
  • PCRX 892.8K
  • MUJ 108.0K
  • Earning Date
  • PCRX 02-27-2025
  • MUJ 01-01-0001
  • Dividend Yield
  • PCRX N/A
  • MUJ 4.36%
  • EPS Growth
  • PCRX N/A
  • MUJ N/A
  • EPS
  • PCRX N/A
  • MUJ N/A
  • Revenue
  • PCRX $694,957,000.00
  • MUJ N/A
  • Revenue This Year
  • PCRX $5.14
  • MUJ N/A
  • Revenue Next Year
  • PCRX $2.44
  • MUJ N/A
  • P/E Ratio
  • PCRX N/A
  • MUJ N/A
  • Revenue Growth
  • PCRX 4.40
  • MUJ N/A
  • 52 Week Low
  • PCRX $11.16
  • MUJ $9.74
  • 52 Week High
  • PCRX $31.67
  • MUJ $11.70
  • Technical
  • Relative Strength Index (RSI)
  • PCRX 77.75
  • MUJ 60.77
  • Support Level
  • PCRX $25.06
  • MUJ $11.31
  • Resistance Level
  • PCRX $27.10
  • MUJ $11.39
  • Average True Range (ATR)
  • PCRX 1.45
  • MUJ 0.09
  • MACD
  • PCRX 0.28
  • MUJ 0.03
  • Stochastic Oscillator
  • PCRX 86.23
  • MUJ 100.00

About PCRX Pacira BioSciences Inc.

Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company has three commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve.

About MUJ Blackrock MuniHoldings New Jersey Quality Fund Inc.

BlackRock MuniHoldings New Jersey Quality Fund Inc is a closed-end management investment company. The investment objective of the company is to provide shareholders with current income exempt from U.S. federal income tax and New Jersey personal income taxes. The fund invests in a portfolio of long-term, investment-grade New Jersey municipal obligations.

Share on Social Networks: